IceCure Medical ICCM Income Statement (2020-2026)

NASDAQ ICCM
$2.46 -0.06 (-2.38%)
At close: Aug 20, 2026 · 10:07 AM UTC
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.68M1.38M0.75M0.77M0.63M0.94M0.71M0.94M0.33M1.25M0.74M1.01M0.66M0.88M0.72M0.53M0.85M1.28M0.91M0.91M
Cost of Revenue (Quarter)
0.59M0.73M0.75M0.79M0.70M-0.60M1.07M1.18M0.98M-1.30M1.04M1.26M1.75M2.25M1.29M0.86M0.92M1.30M1.07M0.65M
Gross Profit (Quarter)
0.36M0.64M0.43M0.38M0.17M0.46M0.32M0.43M-0.02M0.57M0.27M0.53M0.23M0.42M0.22M0.13M0.28M0.60M0.29M0.25M
Operating items
Research & Development (Quarter)
1.55M1.60M2.39M2.25M2.24M2.24M2.11M2.08M2.20M1.88M1.95M1.58M1.86M1.70M1.66M1.71M1.76M2.30M2.21M2.07M
Selling, General & Administrative (Quarter)
1.07M1.47M1.72M1.62M1.32M1.19M1.09M1.26M0.92M0.90M0.93M0.92M0.92M0.99M0.92M0.95M1.44M1.22M1.26M1.16M
Operating Expenses (Quarter)
2.62M3.07M4.11M3.88M3.56M3.43M3.20M3.34M3.12M2.78M2.88M2.50M2.78M2.69M2.59M2.66M3.20M3.52M3.47M3.23M
Operating Income (Quarter)
2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M-12.92M
EBIT (Quarter)
2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M-12.92M
Non-operating items
Interest & Investment Income (Quarter)
-0.07M0.03M
Other Non Operating Income (Quarter)
-0.07M0.08M0.03M
Non Operating Income (Quarter)
0.04M-0.31M0.02M0.24M-0.04M-0.46M-0.19M0.57M-0.89M1.43M-0.04M0.23M-0.14M-0.05M-0.07M-0.02M0.02M0.03M
Net income details
EBT (Quarter)
2.85M-30.53M4.42M4.28M4.10M-46.86M3.96M4.08M4.12M-46.49M3.65M3.23M4.29M4.42M3.59M3.38M3.84M4.22M4.27M-12.92M
Profit After Tax (Quarter)
2.89M-16.63M4.45M4.52M4.06M-30.00M3.77M3.89M4.00M-26.31M3.61M3.08M4.15M4.48M3.59M3.36M3.86M4.25M4.27M-13.05M
Income from Continuing Operations (Quarter)
2.85M-30.53M4.42M4.28M4.10M-46.86M3.96M4.08M4.12M-46.49M3.65M3.23M4.29M4.42M3.59M3.38M3.84M4.22M4.27M-12.92M
Consolidated Net Income (Quarter)
2.85M-30.53M4.42M4.28M4.10M-46.86M3.96M4.08M4.12M-46.49M3.65M3.23M4.29M4.42M3.59M3.38M3.84M4.22M4.27M-12.92M
Income towards Parent Company (Quarter)
2.85M-30.53M4.42M4.28M4.10M-46.86M3.96M4.08M4.12M-46.49M3.65M3.23M4.29M4.42M3.59M3.38M3.84M4.22M4.27M-12.92M
Net Income towards Common Stockholders (Quarter)
2.85M-30.53M4.42M4.28M4.10M-46.86M3.96M4.08M4.12M-46.49M3.65M3.23M4.29M4.42M3.59M3.38M3.84M4.22M4.27M-12.92M
Additional items
EPS (Basic) (Quarter)
3.16-32.083.613.493.34-37.972.602.682.71-30.562.342.022.622.611.871.751.901.991.74-5.27
EPS (Diluted) (Quarter)
3.46-32.084.653.493.34-37.973.212.682.71-30.562.402.022.692.612.121.751.981.992.02-6.10
Shares Outstanding (Quarter)
0.90M0.95M1.23M1.23M1.23M1.23M1.52M1.52M1.52M1.52M1.56M1.60M1.64M1.70M1.92M1.94M2.02M2.12M2.45M2.45M
Shares Outstanding (Diluted) (Quarter)
0.82M0.95M0.95M1.23M1.23M1.23M1.23M1.52M1.52M1.52M1.52M1.60M1.60M1.70M1.70M1.94M1.94M2.12M2.12M2.12M
Shares Outstanding (Entity) (Quarter)
0.90M0.95M1.23M1.23M1.23M1.23M1.52M1.52M1.52M1.52M1.56M1.65M1.64M1.89M1.92M1.96M2.02M2.44M2.45M2.77M
EBITDA (Quarter)
2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M-12.92M
Interest Expenses (Quarter)
14.21M17.31M18.75M0.10M26.94M